BioSpace News Archive

Aptose Presents New Preclinical Data on CG’806 pan-FLT3/pan-BTK Inhibitor at ASH 59th Annual Meeting

Data elucidate unique ability of CG’806 to kill a broad range of AML cells by suppressing multiple pathways, to overcome resistance caused by bone marrow stromal cells, and to act synergistically with other agents.

December 12, 2017

·

7 min read

Galapagos: Transparency Notification - Dec. 12, 2017

Galapagos received a transparency notification from Fidelity Management & Research LLC.

December 12, 2017

·

1 min read

BRAIN AG and Mannheim University of Applied Sciences Jointly Develop 3D Skin Models for Health Care and Cosmetics

As the first milestone of the project, the research partners HS Mannheim and BRAIN have published a review article entitled “in Vitro Skin Three-Dimensional Models and Their Applications” in the Journal of Cellular Biotechnology.

December 12, 2017

·

5 min read

Pharm Country

Fibrocell Announces Closing of $10.5M Underwritten Public Offering

H.C. Wainwright & Co. acted as the sole book-running manager for the Offering.

December 12, 2017

·

4 min read

Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round

Shareholders have until Sunday, December 24th, 2017, at 3:00pm IST to vote their acceptance of the offer.

December 12, 2017

·

3 min read

Deals

Jupiter Life Sciences Consulting Acquires Alta Bioscience Consulting

The acquisition supports Jupiter’s rapid geographic expansion and grows its practice areas and payer network in the pharma and biotech industry.

December 12, 2017

·

2 min read

argenx Announces Launch of Proposed Public Offering in the United States

Each of the ADSs offered in the Offering represents the right to receive one ordinary share, nominal value of €0.10 per share. All of the ADSs in the proposed Offering are to be sold by argenx.

December 12, 2017

·

6 min read

Drug Development

Agios’ Data From Phase I Studies of Ivosidenib or Enasidenib in Combination With Full Doses of Standard of Care Chemotherapy Demonstrate Tolerability and Preliminary Clinical Activity in Newly Diagnosed AML Patients With an IDH Mutation

The data were presented as part of the scientific program at the 59th American Society of Hematology Annual Meeting in Atlanta.

December 12, 2017

·

12 min read

BioMidwest

OrthoPediatrics Corp. Launches New Wrist Fusion Plate System

This plating system is the newest addition to the growing PediFrag franchise.

December 12, 2017

·

2 min read

BioForest

Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH

During ASH, Juno also announced that JCAR017 had received the United States Adopted Name (USAN) lisocabtagene maraleucel (liso-cel).

December 12, 2017

·

12 min read